“To Heiko Braak, we owe fundamental insights on the progression of neurodegenerative diseases in the human brain. He is a pioneer and his work is recognised worldwide,” states Professor Pierluigi Nicotera Professor Pierluigi Nicotera, Chairman of the DZNE’s Executive Board. He notes that Braaks research is groundbreaking, particularly with regards to the spreading of misfolded protein pathology in Alzheimer’s and Parkinson’s diseases. “Braak has discovered that these diseases, which initially develop locally, then propagate through the brain in a characteristic manner. These findings have had a lasting impact on how we see the course of these diseases,” Nicotera says.

“With this award we aim to set an example for excellent science as it provides the foundation for new opportunities of prevention and treatment,” says Olaf Piepenbrock, Managing Partner of the Piepenbrock Group. “In addition, we want to encourage public discussion. Neurodegenerative diseases such as Alzheimer’s and Parkinson’s pose an enormous burden for patients and relatives. Many people experience this day by day among their families and friends. The prize intends to raise public awareness of this situation.”

Every two years the “Hartwig Piepenbrock-DZNE Prize” honors outstanding contributions to the study of neurodegenerative diseases. These diseases, which include Alzheimer’s and Parkinson’s, are characterized by neuronal dysfunctions and the death of nerve cells. This may cause dementia, movement disorders or other health problems. The Prize is endowed by the Piepenbrock Group and awarded in remembrance of its former Chief Executive Officer and Chairman. Hartwig Piepenbrock himself passed away after suffering from dementia. He had been committed to art, science and society for many years. The winner is chosen by an international committee, coordinated by the DZNE. This year, the Prize will be awarded for the fourth time.